Virtual Library
Start Your Search
David Harpole
Moderator of
-
+
Surgically Resectable Session (ID 12)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 10
- Moderators:Marc de Perrot, David Harpole
- Coordinates: 7/12/2019, 08:10 - 09:15, Westin New York at Times Square
-
+
EORTC P/D-Chemo vs. Chemo-P/D (ID 86)
08:10 - 09:15 | Author(s): Paul Baas
- Abstract
Abstract not provided
-
+
EPP vs no EPP (ID 84)
08:10 - 09:15 | Author(s): Jay Lee
- Abstract
Abstract not provided
-
+
NCI-IASLC-MARF Surgical Guidelines (ID 83)
08:10 - 09:15 | Author(s): Joseph Friedberg
- Abstract
Abstract not provided
-
+
Neoadjuvant Dasatinib (ID 87)
08:10 - 09:15 | Author(s): Boris Sepesi
- Abstract
Abstract not provided
-
+
Neoadjuvant Nivolumab/Ipilimumab -Nivolumab (ID 89)
08:10 - 09:15 | Author(s): Patrick Forde
- Abstract
Abstract not provided
-
+
Neoadjuvant Pembrolizumab (ID 88)
08:10 - 09:15 | Author(s): Jay Lee
- Abstract
Abstract not provided
-
+
P/D vs no P/D (ID 85)
08:10 - 09:15 | Author(s): Harvey Pass
- Abstract
Abstract not provided
-
+
S1619 (Chemo-Atezolizumab) (ID 90)
08:10 - 09:15 | Author(s): Anne Tsao
- Abstract
Abstract not provided
-
+
Surgical QOL Assessments (ID 91)
08:10 - 09:15 | Author(s): Mary Hesdorffer, NP
- Abstract
Abstract not provided
-
+
Translational Correlates in I/O trials (ID 92)
08:10 - 09:15 | Author(s): Boris Sepesi
- Abstract
Abstract not provided
Author of
-
+
Debate 3: Neoadjuvant Chemotherapy vs. No Neoadjuvant Therapy (ID 13)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 1
- Moderators:Joseph Friedberg
- Coordinates: 7/12/2019, 09:30 - 10:00, Westin New York at Times Square
-
+
Debate 3: Neoadjuvant Chemotherapy vs. No Neoadjuvant Therapy - CON (ID 95)
09:30 - 10:00 | Author(s): David Harpole
- Abstract
Abstract not provided
